Claraphi Advisory Network’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.34M | Buy |
82,732
+26,068
| +46% | +$736K | 0.93% | 28 |
|
|
2022
Q3 | $1.86M | Sell |
56,664
-13,413
| -19% | -$441K | 1.01% | 20 |
|
|
2022
Q2 | $2.21M | Sell |
70,077
-18,926
| -21% | -$596K | 0.78% | 28 |
|
|
2022
Q1 | $4.09M | Sell |
89,003
-77,863
| -47% | -$3.58M | 1.18% | 14 |
|
|
2021
Q4 | $10.2M | Sell |
166,866
-18,587
| -10% | -$1.14M | 3.56% | 4 |
|
|
2021
Q3 | $13.9M | Sell |
185,453
-88,110
| -32% | -$6.58M | 4.89% | 4 |
|
|
2021
Q2 | $25.3M | Sell |
273,563
-92,541
| -25% | -$8.56M | 7.62% | 2 |
|
|
2021
Q1 | $32.5M | Sell |
366,104
-39,088
| -10% | -$3.47M | 8.95% | 2 |
|
|
2020
Q4 | $37.8M | Buy |
405,192
+99,793
| +33% | +$9.31M | 10.29% | 2 |
|
|
2020
Q3 | $19.5M | Buy |
305,399
+39,164
| +15% | +$2.5M | 7.05% | 2 |
|
|
2020
Q2 | $13.9M | Buy |
266,235
+165,646
| +165% | +$8.64M | 5.92% | 2 |
|
|
2020
Q1 | $3.15M | Sell |
100,589
-41,098
| -29% | -$1.29M | 1.49% | 10 |
|
|
2019
Q4 | $4.75M | Sell |
141,687
-626
| -0.4% | -$21K | 2.91% | 7 |
|
|
2019
Q3 | $4.2M | Buy |
142,313
+78,844
| +124% | +$2.33M | 2.54% | 7 |
|
|
2019
Q2 | $2.19M | Buy |
63,469
+36,476
| +135% | +$1.26M | 1.28% | 11 |
|
|
2019
Q1 | $888K | Buy |
+26,993
| New | +$888K | 0.56% | 34 |
|